Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141905 · ClinicalTrials.gov registry record · NA
Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 342
- Enrollment target
NCT03141905 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 342 participants.
The verdict
NCT03141905, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 342 participants
- Enrollment target
Study Summary
The benefits of renin angiotensin system (RAS) blockers and diuretics for blood pressure control are well-established in chronic kidney diseases (CKD) patients; however, these agents may become hazardous on "sick-days" that lead to volume depletion (dehydration), and increase the risk of kidney function loss and acute kidney injury (AKI). It is not known how frequent significant sick-days occur in CKD patients, or whether a patient self-managed Sick-Day Protocol (SDP) that temporarily holds RAS blocker, diuretics, or other high risk medication in an effort to preserve renal function, or prevent AKI. The purpose of the study is to asses if a SDP, monitored remotely with a weekly automated phone survey , can improve outcomes in CKD (such as slow renal function loss and AKI episodes) and reduce preventable service utilization versus usual care.
Interventions
- OTHER Usual Care
- OTHER Sick-Day Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2020-10-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03141905
The ClinicalTrials.gov registry entry for NCT03141905 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03141905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03141905 about?
NCT03141905 is a clinical study titled "Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease". The benefits of renin angiotensin system (RAS) blockers and diuretics for blood pressure control are well-established in chronic kidney diseases (CKD) patients; however, these agents may become hazardous on "sick-days" that lead to volume depletion (dehydration), and increase the risk of kidney func...
What is the current status of trial NCT03141905?
This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2017-10-16. Estimated completion is 2020-10-07.
What interventions are being tested in trial NCT03141905?
The interventions under investigation include: Usual Care (OTHER), Sick-Day Protocol (OTHER).
Who is sponsoring clinical trial NCT03141905?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.